Cargando…

Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort

BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival...

Descripción completa

Detalles Bibliográficos
Autores principales: op den Winkel, Mark, Nagel, Dorothea, Sappl, Julia, op den Winkel, Philip, Lamerz, Rolf, Zech, Christoph J., Straub, Gundula, Nickel, Thomas, Rentsch, Markus, Stieber, Petra, Göke, Burkhard, Kolligs, Frank T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465308/
https://www.ncbi.nlm.nih.gov/pubmed/23071507
http://dx.doi.org/10.1371/journal.pone.0045066
_version_ 1782245551704637440
author op den Winkel, Mark
Nagel, Dorothea
Sappl, Julia
op den Winkel, Philip
Lamerz, Rolf
Zech, Christoph J.
Straub, Gundula
Nickel, Thomas
Rentsch, Markus
Stieber, Petra
Göke, Burkhard
Kolligs, Frank T.
author_facet op den Winkel, Mark
Nagel, Dorothea
Sappl, Julia
op den Winkel, Philip
Lamerz, Rolf
Zech, Christoph J.
Straub, Gundula
Nickel, Thomas
Rentsch, Markus
Stieber, Petra
Göke, Burkhard
Kolligs, Frank T.
author_sort op den Winkel, Mark
collection PubMed
description BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival rates we analyzed demographic, etiological, clinical, laboratory and tumor characteristics of HCC-patients in our institution and applied the common staging systems. Furthermore we aimed at identifying the most suitable of the current staging systems for predicting survival. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 405 patients with HCC were identified from an electronic medical record database. The following seven staging systems were applied and ranked according to their ability to predict survival by using the Akaike information criterion (AIC) and the concordance-index (c-index): BCLC, CLIP, GETCH, JIS, Okuda, TNM and Child-Pugh. Separately, every single variable of each staging system was tested for prognostic meaning in uni- and multivariate analysis. Alcoholic cirrhosis (44.4%) was the leading etiological factor followed by viral hepatitis C (18.8%). Median survival was 18.1 months (95%-CI: 15.2–22.2). Ascites, bilirubin, alkaline phosphatase, AFP, number of tumor nodes and the BCLC tumor extension remained independent prognostic factors in multivariate analysis. Overall, all of the tested staging systems showed a reasonable discriminatory ability. CLIP (closely followed by JIS) was the top-ranked score in terms of prognostic capability with the best values of the AIC and c-index (AIC 2286, c-index 0.71), surpassing other established staging systems like BCLC (AIC 2343, c-index 0.66). The unidimensional scores TNM (AIC 2342, c-index 0.64) and Child-Pugh (AIC 2369, c-index 0.63) performed in an inferior fashion. CONCLUSIONS/SIGNIFICANCE: Compared with six other staging systems, the CLIP-score was identified as the most suitable staging system for predicting prognosis in a large German cohort of predominantly non-surgical HCC-patients.
format Online
Article
Text
id pubmed-3465308
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34653082012-10-15 Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort op den Winkel, Mark Nagel, Dorothea Sappl, Julia op den Winkel, Philip Lamerz, Rolf Zech, Christoph J. Straub, Gundula Nickel, Thomas Rentsch, Markus Stieber, Petra Göke, Burkhard Kolligs, Frank T. PLoS One Research Article BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival rates we analyzed demographic, etiological, clinical, laboratory and tumor characteristics of HCC-patients in our institution and applied the common staging systems. Furthermore we aimed at identifying the most suitable of the current staging systems for predicting survival. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 405 patients with HCC were identified from an electronic medical record database. The following seven staging systems were applied and ranked according to their ability to predict survival by using the Akaike information criterion (AIC) and the concordance-index (c-index): BCLC, CLIP, GETCH, JIS, Okuda, TNM and Child-Pugh. Separately, every single variable of each staging system was tested for prognostic meaning in uni- and multivariate analysis. Alcoholic cirrhosis (44.4%) was the leading etiological factor followed by viral hepatitis C (18.8%). Median survival was 18.1 months (95%-CI: 15.2–22.2). Ascites, bilirubin, alkaline phosphatase, AFP, number of tumor nodes and the BCLC tumor extension remained independent prognostic factors in multivariate analysis. Overall, all of the tested staging systems showed a reasonable discriminatory ability. CLIP (closely followed by JIS) was the top-ranked score in terms of prognostic capability with the best values of the AIC and c-index (AIC 2286, c-index 0.71), surpassing other established staging systems like BCLC (AIC 2343, c-index 0.66). The unidimensional scores TNM (AIC 2342, c-index 0.64) and Child-Pugh (AIC 2369, c-index 0.63) performed in an inferior fashion. CONCLUSIONS/SIGNIFICANCE: Compared with six other staging systems, the CLIP-score was identified as the most suitable staging system for predicting prognosis in a large German cohort of predominantly non-surgical HCC-patients. Public Library of Science 2012-10-05 /pmc/articles/PMC3465308/ /pubmed/23071507 http://dx.doi.org/10.1371/journal.pone.0045066 Text en © 2012 op den Winkel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
op den Winkel, Mark
Nagel, Dorothea
Sappl, Julia
op den Winkel, Philip
Lamerz, Rolf
Zech, Christoph J.
Straub, Gundula
Nickel, Thomas
Rentsch, Markus
Stieber, Petra
Göke, Burkhard
Kolligs, Frank T.
Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title_full Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title_fullStr Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title_full_unstemmed Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title_short Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
title_sort prognosis of patients with hepatocellular carcinoma. validation and ranking of established staging-systems in a large western hcc-cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465308/
https://www.ncbi.nlm.nih.gov/pubmed/23071507
http://dx.doi.org/10.1371/journal.pone.0045066
work_keys_str_mv AT opdenwinkelmark prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT nageldorothea prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT sappljulia prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT opdenwinkelphilip prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT lamerzrolf prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT zechchristophj prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT straubgundula prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT nickelthomas prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT rentschmarkus prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT stieberpetra prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT gokeburkhard prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort
AT kolligsfrankt prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort